230 related articles for article (PubMed ID: 11347507)
1. [Clinical features and response to systemic treatment of primary and secondary episcleritis and scleritis resistant to local treatment].
Cuchacovich T M; Pacheco P; Merino G; Gallardo P; Gatica H; Valenzuela H; Verdaguer J; Verdaguer J
Rev Med Chil; 2000 Nov; 128(11):1205-14. PubMed ID: 11347507
[TBL] [Abstract][Full Text] [Related]
2. Severity of scleritis and episcleritis.
Sainz de la Maza M; Jabbur NS; Foster CS
Ophthalmology; 1994 Feb; 101(2):389-96. PubMed ID: 8115160
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics of a large cohort of patients with scleritis and episcleritis.
Sainz de la Maza M; Molina N; Gonzalez-Gonzalez LA; Doctor PP; Tauber J; Foster CS
Ophthalmology; 2012 Jan; 119(1):43-50. PubMed ID: 21963265
[TBL] [Abstract][Full Text] [Related]
4. [Clinical characteristics of 4 cases of scleritis associated with systemic lupus erythematosus].
Wang L; Yang Y; Jia Y; Miao H; Zhou YS; Zhang XY
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):1081-1085. PubMed ID: 27987518
[TBL] [Abstract][Full Text] [Related]
5. [Study on the clinical manifestation of 90 cases with scleritis and episcleritis].
Zhou Y; Wang Z; Zhang Y; Sun X
Zhonghua Yan Ke Za Zhi; 2014 Apr; 50(4):261-6. PubMed ID: 24931151
[TBL] [Abstract][Full Text] [Related]
6. Severity of episcleritis and systemic disease association.
Akpek EK; Uy HS; Christen W; Gurdal C; Foster CS
Ophthalmology; 1999 Apr; 106(4):729-31. PubMed ID: 10201593
[TBL] [Abstract][Full Text] [Related]
7. Clinical features of patients with episcleritis and scleritis in an Italian tertiary care referral center.
Berchicci L; Miserocchi E; Di Nicola M; La Spina C; Bandello F; Modorati G
Eur J Ophthalmol; 2014; 24(3):293-8. PubMed ID: 24242216
[TBL] [Abstract][Full Text] [Related]
8. Episcleritis and scleritis: clinical features and treatment results.
Jabs DA; Mudun A; Dunn JP; Marsh MJ
Am J Ophthalmol; 2000 Oct; 130(4):469-76. PubMed ID: 11024419
[TBL] [Abstract][Full Text] [Related]
9. [Indication and effect of immunosuppression in patients with scleritis].
Heiligenhaus A; Dück N; Michel D; Hudde T; Koch J; Steuhl KP
Klin Monbl Augenheilkd; 2003 Jul; 220(7):471-80. PubMed ID: 12886507
[TBL] [Abstract][Full Text] [Related]
10. [Episcleritis and scleritis. An overview of modern diagnostic and therapeutic concepts].
Denk PO; Thiel HJ; Zierhut M
Klin Monbl Augenheilkd; 1997 Sep; 211(3):140-50. PubMed ID: 9445894
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics of scleritis patients with emphasized comparison of associated systemic diseases (anti-neutrophil cytoplasmic antibody-associated vasculitis and rheumatoid arthritis).
Yoshida A; Watanabe M; Okubo A; Kawashima H
Jpn J Ophthalmol; 2019 Sep; 63(5):417-424. PubMed ID: 31183624
[TBL] [Abstract][Full Text] [Related]
12. Cyclo-oxygenase inhibitors in the treatment of chronic non-infectious, non-necrotizing scleritis and episcleritis.
Kolomeyer AM; Ragam A; Shah K; Do BK; Shah VP; Chu DS
Ocul Immunol Inflamm; 2012 Aug; 20(4):293-9. PubMed ID: 22642498
[TBL] [Abstract][Full Text] [Related]
13. [Diagnosis and treatment of episcleritis and scleritis].
Tappeiner C; Walscheid K; Heiligenhaus A
Ophthalmologe; 2016 Sep; 113(9):797-810. PubMed ID: 27550224
[TBL] [Abstract][Full Text] [Related]
14. Scleritis associated with systemic vasculitic diseases.
Sainz de la Maza M; Foster CS; Jabbur NS
Ophthalmology; 1995 Apr; 102(4):687-92. PubMed ID: 7724185
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic and Therapeutic Management of Episcleritis and Scleritis].
Turgut F; Dingerkus V; Tappeiner C; Becker M
Klin Monbl Augenheilkd; 2023 May; 240(5):725-738. PubMed ID: 36827997
[TBL] [Abstract][Full Text] [Related]
16. Clinical Correlates, Outcomes, and Predictors of Inflammatory Ocular Disease Associated with Rheumatoid Arthritis in the Biologic Era.
Caimmi C; Crowson CS; Smith WM; Matteson EL; Makol A
J Rheumatol; 2018 May; 45(5):595-603. PubMed ID: 29449499
[TBL] [Abstract][Full Text] [Related]
17. [New clinical and epidemiologic aspects of episcleritis and scleritis].
Denk PO; Rohrbach JM; Thiel HJ; Zierhut M
Ophthalmologe; 1997 Mar; 94(3):202-5. PubMed ID: 9181836
[TBL] [Abstract][Full Text] [Related]
18. Smoking delays the response to treatment in episcleritis and scleritis.
Boonman ZF; de Keizer RJ; Watson PG
Eye (Lond); 2005 Sep; 19(9):949-55. PubMed ID: 15543188
[TBL] [Abstract][Full Text] [Related]
19. Clinical features of episcleritis and scleritis in some Japanese patients.
Nakajima N; Hayasaka S
Ophthalmologica; 1995; 209(5):256-9. PubMed ID: 8570148
[TBL] [Abstract][Full Text] [Related]
20. [Scleritis and episcleritis: diagnosis and treatment].
Héron E; Gutzwiller-Fontaine M; Bourcier T
Rev Med Interne; 2014 Sep; 35(9):577-85. PubMed ID: 24636988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
